Modified beta-lactoglobulins for immunotherapy of milk allergy
US8877894B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2009 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Nov 22, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/4717
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to field of allergic (hypersensitivity) diseases and provides a method for producing modified allergenic polypeptides for use in immunotherapies. In the method of the invention, said allergenic polypeptides are modified so that they are not capable to form transient dimers. The invention also provides modified β-lactoglobulins for use in immunotherapy of milk allergy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.